AGILE PMO LTD
Executive Summary
AGILE PMO LTD demonstrates a solid financial foundation typical of a newly founded micro-entity with positive net assets and manageable liabilities. While current financials show no distress, the company should focus on monitoring cash flow and capturing operational data to ensure sustained growth and financial health. With prudent management and strategic planning, the company’s outlook remains positive as it develops beyond its start-up phase.
View Full Analysis Report →Company Analysis
This analysis is opinion only and should not be interpreted as financial advice.
AGILE PMO LTD - Analysis Report
Financial Health Assessment of AGILE PMO LTD
1. Financial Health Score: B
Explanation:
AGILE PMO LTD shows a sound start typical for a newly incorporated micro-entity. Its positive net current assets and net assets indicate a stable foundation with no immediate liquidity distress. However, the company’s financial history is limited due to its recent formation, and absence of turnover and profit data restricts a full diagnostic. The "B" grade reflects a generally healthy financial position with room for more robust performance data and growth.
2. Key Vital Signs
Metric | Value (£) | Interpretation |
---|---|---|
Current Assets | 54,150 | Healthy level of liquid and short-term assets available to cover obligations. |
Current Liabilities | 42,904 | Short-term debts are significant but fully covered by current assets, indicating manageable risk. |
Net Current Assets | 11,246 | Positive working capital; "healthy cash flow" indicator suggesting ability to meet short-term debts. |
Net Assets (Equity) | 11,246 | Positive net worth; company holds more assets than liabilities, indicating financial solvency. |
Share Capital | 2.00 | Nominal share capital typical for micro-entities; low initial investment. |
Average Employees | 0 | No employees currently, implying low fixed operating costs but potential capacity constraints. |
Account Category | Micro | Simplified filing and reporting, limited historical data for trend analysis. |
Company Age | ~1 year | Very early stage of business lifecycle; limited data for performance or profitability trends. |
3. Diagnosis
AGILE PMO LTD is in the "early adopter" phase of its financial lifecycle, showing no signs of distress or liquidity crunch. The positive net current assets are like a "healthy pulse," reflecting sufficient short-term assets to cover liabilities. The balance sheet is solvent with net assets exceeding liabilities, indicating no "symptoms of distress" such as negative equity or working capital deficits.
The absence of employees and profit and loss figures is typical for a newly set-up consultancy service, possibly reflecting outsourced operations or owners providing services directly. The micro-entity filing regime means limited disclosure, but the current financial snapshot suggests prudent financial management with modest capital and controlled liabilities.
However, as a company just over a year old, the prognosis depends heavily on future trading results, cash flow generation, and ability to grow revenue sustainably. The current "healthy cash flow" position must be maintained or improved once trading activities intensify.
4. Recommendations
- Cash Flow Monitoring: Maintain close monitoring of cash inflows and outflows as trading activity grows to avoid liquidity strain.
- Revenue Tracking: Begin capturing and reporting turnover and profit data to better assess operational efficiency and profitability.
- Cost Control: With zero employees, the cost base is low, but plan for potential staffing or outsourcing expenses as the business scales.
- Financial Planning: Develop a financial forecast and budgeting process to anticipate working capital needs and investment requirements.
- Compliance Maintenance: Continue timely filing of accounts and confirmation statements to avoid penalties and maintain good standing.
- Consider Audit Preparation: As business grows beyond micro thresholds, prepare for more comprehensive accounting and potential audit requirements.
- Capital Injection: Consider additional equity or funding sources if expansion or capital expenditure is planned to strengthen the financial base.
More Company Information
Recently Viewed
Follow Company
- Receive an alert email on changes to financial status
- Early indications of liquidity problems
- Warns when company reporting is overdue
- Free service, no spam emails Follow this company